- Home
- BCRX vs HP Comparison
BCRX vs HP Comparison
Compare BCRX & HP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCRX
- HP
- Stock Information
- Founded
- BCRX 1986
- HP 1920
- Country
- BCRX United States
- HP United States
- Employees
- BCRX N/A
- HP N/A
- Industry
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- HP Oil & Gas Production
- Sector
- BCRX Health Care
- HP Energy
- Exchange
- BCRX Nasdaq
- HP Nasdaq
- Market Cap
- BCRX 1.7B
- HP 1.9B
- IPO Year
- BCRX 1994
- HP N/A
- Fundamental
- Price
- BCRX $9.19
- HP $15.46
- Analyst Decision
- BCRX Buy
- HP Hold
- Analyst Count
- BCRX 9
- HP 11
- Target Price
- BCRX $16.89
- HP $26.60
- AVG Volume (30 Days)
- BCRX 3.6M
- HP 2.4M
- Earning Date
- BCRX 08-04-2025
- HP 07-23-2025
- Dividend Yield
- BCRX N/A
- HP 6.50%
- EPS Growth
- BCRX N/A
- HP N/A
- EPS
- BCRX N/A
- HP 2.20
- Revenue
- BCRX $503,485,000.00
- HP $3,084,858,000.00
- Revenue This Year
- BCRX $39.04
- HP $38.00
- Revenue Next Year
- BCRX $13.26
- HP $5.91
- P/E Ratio
- BCRX N/A
- HP $7.00
- Revenue Growth
- BCRX 41.67
- HP 12.23
- 52 Week Low
- BCRX $6.02
- HP $14.65
- 52 Week High
- BCRX $11.31
- HP $42.60
- Technical
- Relative Strength Index (RSI)
- BCRX 34.12
- HP 36.42
- Support Level
- BCRX $9.19
- HP $17.39
- Resistance Level
- BCRX $10.07
- HP $18.80
- Average True Range (ATR)
- BCRX 0.34
- HP 0.86
- MACD
- BCRX -0.18
- HP -0.13
- Stochastic Oscillator
- BCRX 8.10
- HP 2.50
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About HP Helmerich & Payne Inc.
Helmerich & Payne Inc provides performance-driven drilling solutions and technologies that are intended to make hydrocarbon recovery safer and more economical for oil and gas exploration and production companies. The Company focus on the drilling segment of the oil and gas production value chain. Company operates in North America, Gulf of Mexico, and other international places such as Argentina, Australia, Bahrain, Colombia and the United Arab Emirates (UAE). Also own and operates a limited number of commercial real estate properties located in Tulsa, Oklahoma. It's real estate investments include a shopping center and of undeveloped real estate projects.